SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,943 | -53.6% | 56,544 | 0.0% | 0.00% | – |
| Q2 2023 | $73,224 | -25.4% | 56,544 | 0.0% | 0.00% | – |
| Q1 2023 | $98,104 | -38.3% | 56,544 | +8.1% | 0.00% | – |
| Q4 2022 | $158,980 | -39.3% | 52,297 | 0.0% | 0.00% | – |
| Q3 2022 | $262,000 | +40.1% | 52,297 | +15.6% | 0.00% | – |
| Q2 2022 | $187,000 | +98.9% | 45,238 | +184.3% | 0.00% | – |
| Q1 2022 | $94,000 | -53.5% | 15,914 | -28.2% | 0.00% | – |
| Q3 2021 | $202,000 | +16.1% | 22,158 | +100.8% | 0.00% | – |
| Q4 2020 | $174,000 | -55.9% | 11,036 | -75.0% | 0.00% | -100.0% |
| Q2 2020 | $395,000 | +98.5% | 44,086 | +37.6% | 0.00% | – |
| Q1 2020 | $199,000 | -31.6% | 32,038 | +5.0% | 0.00% | -100.0% |
| Q1 2019 | $291,000 | -61.3% | 30,500 | -53.4% | 0.00% | 0.0% |
| Q4 2018 | $752,000 | +1988.9% | 65,508 | +447.7% | 0.00% | – |
| Q4 2016 | $36,000 | – | 11,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
| EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
| FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
| Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
| DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
| RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
| Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
| Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
| WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
| Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |